Kansas began its investigation into Centene in 2019, after a similar effort in Ohio revealed pharmacy benefit managers were overbilling states. Kansas’ investigation concluded that Centene artificially inflated dispensing fee amounts reported to state regulators and failed to report discounts it received from CVS-Caremark on certain retail pharmacy claims.
The settlement covers Centene’s alleged practices between Jan. 1, 2016, and Nov. 12, 2021.
In the settlement, Centene agreed to improve transparency by providing Kansas with access to data necessary to determine the nature and appropriateness of pharmacy transactions.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.